Background Antiphospholipid syndrome (APS) is an autoimmune condition that is
diagnosed by the presence of at least one of the clinical manifestations (thrombosis and/or …

Background Antiphospholipid syndrome (APS) is characterized by the presence circulating
antiphospholipid (aPL) antibodies in patients with thrombosis or pregnancy morbidity …

Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by clinical
symptoms of vascular thrombosis and/or pregnancy morbidity in the presence of …

The antiphospholipid antibody syndrome (APS) is defined by two major elements: the
presence in plasma of auto‐antibodies, ie antiphospholipid antibodies and the occurrence …

Antiphospholipid syndrome (APS) is an autoimmune disease characterized by thrombotic
manifestations and/or obstetric complications in patients with persistently positive …

The antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by
thrombosis and/or obstetrical manifestations and the persistent presence, at least 12 weeks …

The updated international consensus criteria for definite antiphospholipid syndrome (APS)
are useful for scientific clinical studies. However, there remains a need for diagnostic criteria …

Antiphospholipid antibodies (aPLs) are associated with arterial and venous thrombosis,
recurrent pregnancy loss and thrombocytopenia. Although aPLs have not yet been …

The antiphospholipid syndrome is a bioclinical entity defined by thrombosis and/or
obstetrical complications in the presence, at least 12 weeks apart, of antiphospholipid …

The antiphospholipid syndrome (APS) is an autoimmune disorder characterized by the
occurrence of venous and arterial thromboses, often multiple, and obstetric-related adverse …